Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
Masclee GM, Valkhoff VE, van Soest EM, Schade R, Mazzaglia G, Molokhia M, Trifirò G, Goldstein JL, Hernández-Díaz S, Kuipers EJ, Sturkenboom MC. Masclee GM, et al. Among authors: mazzaglia g. Aliment Pharmacol Ther. 2013 Jul;38(2):178-89. doi: 10.1111/apt.12348. Epub 2013 May 28. Aliment Pharmacol Ther. 2013. PMID: 23710837 Free PMC article.
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study.
Herrera L, Leal I, Lapi F, Schuemie M, Arcoraci V, Cipriani F, Sessa E, Vaccheri A, Piccinni C, Staniscia T, Vestri A, Di Bari M, Corrao G, Zambon A, Gregori D, Carle F, Sturkenboom M, Mazzaglia G, Trifiro G. Herrera L, et al. Among authors: mazzaglia g. Osteoporos Int. 2015 May;26(5):1499-506. doi: 10.1007/s00198-014-3020-y. Epub 2015 Mar 10. Osteoporos Int. 2015. PMID: 25752621 Free PMC article.
Risk of severe upper gastrointestinal complications among oral bisphosphonate users.
Ghirardi A, Scotti L, Zambon A, Della Vedova G, Cavalieri D'oro L, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; BEST Investigators. Ghirardi A, et al. Among authors: mazzaglia g. PLoS One. 2013 Dec 9;8(12):e73159. doi: 10.1371/journal.pone.0073159. eCollection 2013. PLoS One. 2013. PMID: 24348985 Free PMC article.
Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study.
Ghirardi A, Scotti L, Vedova GD, D'Oro LC, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; AIFA-BEST Investigators. Ghirardi A, et al. Among authors: mazzaglia g. BMC Gastroenterol. 2014 Jan 7;14:5. doi: 10.1186/1471-230X-14-5. BMC Gastroenterol. 2014. PMID: 24397769 Free PMC article.
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.
Lapi F, Cipriani F, Caputi AP, Corrao G, Vaccheri A, Sturkenboom MC, Di Bari M, Gregori D, Carle F, Staniscia T, Vestri A, Brandi M, Fusco V, Campisi G, Mazzaglia G; Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group. Lapi F, et al. Among authors: mazzaglia g. Osteoporos Int. 2013 Feb;24(2):697-705. doi: 10.1007/s00198-012-2013-y. Epub 2012 May 23. Osteoporos Int. 2013. PMID: 22618266
Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study.
Ghirardi A, Di Bari M, Zambon A, Scotti L, Della Vedova G, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; BEST investigators. Ghirardi A, et al. Among authors: mazzaglia g. Eur J Clin Pharmacol. 2014 Sep;70(9):1129-37. doi: 10.1007/s00228-014-1708-8. Epub 2014 Jun 22. Eur J Clin Pharmacol. 2014. PMID: 24951915
154 results